{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:46:54Z","timestamp":1780451214739,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12185-016-2127-7","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T06:23:54Z","timestamp":1479191034000},"page":"377-382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pediatric intestinal Beh\u00e7et disease complicated by myeloid malignancies"],"prefix":"10.1007","volume":"105","author":[{"given":"Kiichiro","family":"Kanamitsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5207-3779","authenticated-orcid":false,"given":"Akira","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuo","family":"Nishiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonari","family":"Shigemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yozo","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Shinkoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozo","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Kajiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,15]]},"reference":[{"key":"2127_CR1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10067-010-1430-6","volume":"29","author":"F Davatchi","year":"2010","unstructured":"Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, et al. Behcet\u2019s disease: from East to West. Clin Rheumatol. 2010;29:823\u201333.","journal-title":"Clin Rheumatol"},{"key":"2127_CR2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0022-3476(98)70368-3","volume":"132","author":"I Kon\u00e9-Paut","year":"1998","unstructured":"Kon\u00e9-Paut I, Yurdakul S, Bahabri SA, Shafae N, Ozen S, Ozdogan H, et al. Clinical features of Beh\u00e7et\u2019s disease in children: an international collaborative study of 86 cases. J Pediatr. 1998;132:721\u20135.","journal-title":"J Pediatr"},{"key":"2127_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1442-200X.1997.tb03601.x","volume":"39","author":"S Fujikawa","year":"1997","unstructured":"Fujikawa S, Suemitsu T. Beh\u00e7et disease in children: a nationwide retrospective survey in Japan. Acta Paediatr Jpn. 1997;39:285\u20139.","journal-title":"Acta Paediatr Jpn"},{"key":"2127_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPH.0000000000000046","volume":"36","author":"T Glaubach","year":"2014","unstructured":"Glaubach T, Robinson LJ, Corey SJ. Pediatric myelodysplastic syndromes: they do exist! J Pediatr Hematol Oncol. 2014;36:1\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2127_CR5","first-page":"S91","volume":"23","author":"L Eder","year":"2005","unstructured":"Eder L, Rozenbaum M, Boulman N, Aayubkhanov E, Wolfovitz E, Zisman D, et al. Beh\u00e7et\u2019s disease, myelodysplastic syndrome, trisomy 8, gastroenterological involvement\u2013an association. Clin Exp Rheumatol. 2005;23:S91\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"2127_CR6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/s10165-010-0291-9","volume":"20","author":"T Fujimura","year":"2010","unstructured":"Fujimura T, Yukawa N, Nakashima R, Imura Y, Kawabata D, Nojima T, et al. Periodic fever and erythema nodosum associated with MDS with trisomy 8: report of two cases and review of the literature. Mod Rheumatol. 2010;20:413\u20139.","journal-title":"Mod Rheumatol"},{"key":"2127_CR7","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2169\/internalmedicine.45.1718","volume":"45","author":"H Kawabata","year":"2006","unstructured":"Kawabata H, Sawaki T, Kawanami T, Shimoyama K, Karasawa H, Fukushima T, et al. Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Intern Med. 2006;45:1309\u201314.","journal-title":"Intern Med"},{"key":"2127_CR8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF02982607","volume":"77","author":"K Yamato","year":"2003","unstructured":"Yamato K. Successful cord blood stem cell transplantation for myelodysplastic syndrome with Beh\u00e7et disease. Int J Hematol. 2003;77:82\u20135.","journal-title":"Int J Hematol"},{"key":"2127_CR9","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/rheumatology\/ker137","volume":"50","author":"T Shigemura","year":"2011","unstructured":"Shigemura T, Agematsu K, Yamazaki T, Sakashita K, Nakayama Y, Higuchi Y, et al. A case of Behcet\u2019s disease associated with myelodysplastic syndrome involving trisomy 8 and a gain-of-function mutation in SHP-2. Rheumatology (Oxford). 2011;50:1342\u20134.","journal-title":"Rheumatology (Oxford)"},{"key":"2127_CR10","first-page":"3","volume":"54","author":"A Ohta","year":"2007","unstructured":"Ohta A, Nagai M, Nishina M, Shibazaki S, Ishijima H, Izumida M. Age at the onset of intractable disease: based on a clinical database for patients receiving financial aid for treatment (in Japanese). Nihon Koshu Eisei Zasshi. 2007;54:3\u201314.","journal-title":"Nihon Koshu Eisei Zasshi"},{"key":"2127_CR11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","volume":"11","author":"C Evereklioglu","year":"2002","unstructured":"Evereklioglu C, Er H, T\u00fcrk\u00f6z Y, Cekmen M. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Beh\u00e7et\u2019s disease. Mediators Inflamm. 2002;11:87\u201393.","journal-title":"Mediators Inflamm"},{"key":"2127_CR12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cyto.2003.09.003","volume":"24","author":"M Misumi","year":"2003","unstructured":"Misumi M, Hagiwara E, Takeno M, Takeda Y, Inoue Y, Tsuji T, et al. Cytokine production profile in patients with Behcet\u2019s disease treated with infliximab. Cytokine. 2003;24:210\u20138.","journal-title":"Cytokine"},{"key":"2127_CR13","first-page":"265","volume":"79","author":"P Musto","year":"1994","unstructured":"Musto P, Matera R, Minervini MM, Checchia-de Ambrosio C, Bodenizza C, Falcone A, et al. Low serum levels of tumor necrosis factor and interleukin-1 beta in myelodysplastic syndromes responsive to recombinant erythropoietin. Haematologica. 1994;79:265\u20138.","journal-title":"Haematologica"},{"key":"2127_CR14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2257.1997.tb00007.x","volume":"19","author":"R Stasi","year":"1997","unstructured":"Stasi R, Brunetti M, Bussa S, Conforti M, Martin LS, La Presa M, et al. Serum levels of tumour necrosis factor-alpha predict response to recombinant human erythropoietin in patients with myelodysplastic syndrome. Clin Lab Haematol. 1997;19:197\u2013201.","journal-title":"Clin Lab Haematol"},{"key":"2127_CR15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.arcmed.2010.02.002","volume":"41","author":"Z Touma","year":"2010","unstructured":"Touma Z, Farra C, Hamdan A, Shamseddeen W, Uthman I, Hourani H, et al. TNF polymorphisms in patients with Beh\u00e7et disease: a meta-analysis. Arch Med Res. 2010;41:142\u20136.","journal-title":"Arch Med Res"},{"key":"2127_CR16","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V99.5.1594","volume":"99","author":"Y-E Claessens","year":"2002","unstructured":"Claessens Y-E, Bouscary D, Dupont J-M, Picard F, Melle J, Gisselbrecht S, et al. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis. Blood. 2002;99:1594\u2013601.","journal-title":"Blood"},{"key":"2127_CR17","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V85.11.3183.bloodjournal85113183","volume":"85","author":"J Maciejewski","year":"1995","unstructured":"Maciejewski J, Selleri C, Anderson S, Young NS. Fas antigen expression on CD34\u00a0+\u00a0human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 1995;85:3183\u201390.","journal-title":"Blood"},{"key":"2127_CR18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10875-006-9064-9","volume":"27","author":"K Arimura","year":"2007","unstructured":"Arimura K, Arima N, Matsushita K, Akimoto M, Park CY, Uozumi K, et al. High incidence of morphological myelodysplasia and apoptotic bone marrow cells in Beh\u00e7et\u2019s disease. J Clin Immunol. 2007;27:145\u201351.","journal-title":"J Clin Immunol"},{"key":"2127_CR19","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1182\/blood-2004-01-0103","volume":"104","author":"G Chen","year":"2004","unstructured":"Chen G, Zeng W, Miyazato A, Billings E, Maciejewski JP, Kajigaya S, et al. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood. 2004;104:4210\u20138.","journal-title":"Blood"},{"key":"2127_CR20","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1182\/blood-2002-01-0096","volume":"100","author":"EM Sloand","year":"2002","unstructured":"Sloand EM, Kim S, Fuhrer M, Risitano AM, Nakamura R, Maciejewski JP, et al. Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities. Blood. 2002;100:4427\u201332.","journal-title":"Blood"},{"key":"2127_CR21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood-2004-05-2017","volume":"106","author":"EM Sloand","year":"2005","unstructured":"Sloand EM, Mainwaring L, Fuhrer M, Ramkissoon S, Risitano AM, Keyvanafar K, et al. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. Blood. 2005;106:841\u201351.","journal-title":"Blood"},{"key":"2127_CR22","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1182\/blood-2006-01-030643","volume":"109","author":"EM Sloand","year":"2007","unstructured":"Sloand EM, Pfannes L, Chen G, Shah S, Solomou EE, Barrett J, et al. CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins. Blood. 2007;109:2399\u2013405.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-016-2127-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-016-2127-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-016-2127-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T09:03:12Z","timestamp":1601197392000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-016-2127-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,15]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["2127"],"URL":"https:\/\/doi.org\/10.1007\/s12185-016-2127-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,15]]}}}